Immunic (IMUX) Return on Equity [ROE] (2014 - 2026)
Immunic (IMUX) reported Return on Equity [ROE] of -82.65% for Q2 2026, up 641.47 percentage points from -724.12% a year earlier and up 66.80 percentage points from the prior quarter.
Immunic (IMUX) Return on Equity [ROE] (2014 - 2026) Analysis & Trends
For FY2025, Immunic posted Return on Equity [ROE] of -1738.48%, down 1338.73 percentage points from FY2024.
- Return on Equity [ROE] has declined for five consecutive years, with a five-year change of -1693.43 percentage points (FY2020 to FY2025).
- By year, Return on Equity [ROE] came in at -399.76% in FY2024 (-264.92 pp), -134.84% in FY2023 (-36.46 pp), -98.38% in FY2022 (-34.30 pp) and -64.08% in FY2021 (-19.03 pp).
- The Q2 2026 figure ranks as the highest quarterly Return on Equity [ROE] since Q3 2022.
- Year over year, Return on Equity [ROE] gained in three of the last eight quarters, with an average year-over-year change of -660.90 percentage points.
- The high point for year-over-year Return on Equity [ROE] in five years was Q1 2026 (a gain of 1351.24 percentage points); the low point was Q4 2025 (a drop of 5024.36 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -149.45% (Q1 2026), -5341.77% (Q4 2025) and -469.53% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Immunic | 338.41 Mn | 338.41 Mn | - | -82.65% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -82.65% |
| Mar 31, 2026 | -149.45% |
| Dec 31, 2025 | -5,341.77% |
| Sep 30, 2025 | -469.53% |
| Jun 30, 2025 | -724.12% |
| Mar 31, 2025 | -1,500.68% |
| Dec 31, 2024 | -317.40% |
| Sep 30, 2024 | -176.16% |
| Jun 30, 2024 | -122.53% |
| Mar 31, 2024 | -164.24% |
| Dec 31, 2023 | -248.64% |
| Sep 30, 2023 | -220.81% |
| Jun 30, 2023 | -158.28% |
| Mar 31, 2023 | -120.52% |
| Dec 31, 2022 | -106.47% |
| Sep 30, 2022 | -70.59% |
| Jun 30, 2022 | -61.71% |
| Mar 31, 2022 | -60.86% |
| Dec 31, 2021 | -67.21% |
| Sep 30, 2021 | -63.16% |
Immunic Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=IMUX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "IMUX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=IMUX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();